![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Preinitiation |
Unique ID issued by UMIN | UMIN000046688 |
Receipt No. | R000053259 |
Scientific Title | A study to evaluate the effect after using diaper XI |
Date of disclosure of the study information | 2022/01/21 |
Last modified on | 2022/01/21 |
Basic information | ||
Public title | A study to evaluate the effect after using diaper XI | |
Acronym | A study to evaluate the effect after using diaper XI | |
Scientific Title | A study to evaluate the effect after using diaper XI | |
Scientific Title:Acronym | A study to evaluate the effect after using diaper XI | |
Region |
|
Condition | |||
Condition | Healthy baby | ||
Classification by specialty |
|
||
Classification by malignancy | Others | ||
Genomic information | NO |
Objectives | |
Narrative objectives1 | To evaluate the dermatological effect after using baby diaper |
Basic objectives2 | Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Skin condition before the use of test diaper, after 1 weeks, after 2 weeks and 2 weeks after returning to favorite diaper. |
Key secondary outcomes | Skin microflora before the use of test diaper, after 1 weeks, after 2 weeks and 2 weeks after returning to favorite diaper.
Ingredient of sebum before the use of test diaper, after 1 weeks and after 2 weeks. |
Base | |
Study type | Interventional |
Study design | |
Basic design | Parallel |
Randomization | Randomized |
Randomization unit | Individual |
Blinding | Single blind -participants are blinded |
Control | Active |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 2 | |
Purpose of intervention | Treatment | |
Type of intervention |
|
|
Interventions/Control_1 | Use the test diaper for 14 days, following the favorite diaper for 14 days. | |
Interventions/Control_2 | Use the control diaper for 14 days, following the favorite diaper for 14 days. | |
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | 1. 3-8 months old (less than 7.5kg) Japanese infants who lives in or near Tokyo.
2. Infants who use tape-type s size diaper all day. 3. Infants whose parents admit that they are worried about diaper dermatitis. |
|||
Key exclusion criteria | 1. Infants who are under medical treatment or on medication for skin trouble.
2. Infants who were diagnosed with any disease among chronic disease and congenital disorder. 3. Infants who were affected with infectious disorder from one month before the start of the test to the start of the test. 4. Infants who used antibiotics, steroids, or medicated cleaning agents from one month before the start of the test to the start of the test. |
|||
Target sample size | 80 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Kao Corporation | ||||||
Division name | R&D -Development Research-Sanitary Products Research | ||||||
Zip code | 321-3497 | ||||||
Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN | ||||||
TEL | 0285-68-7597 | ||||||
fukuda.yuuko1@kao.com |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Kao Corporation | ||||||
Division name | R&D -Development Research-Sanitary Products Research | ||||||
Zip code | 321-3497 | ||||||
Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN | ||||||
TEL | 0285-68-7285 | ||||||
Homepage URL | |||||||
sagara.sanae@kao.com |
Sponsor | |
Institute | Kao Corporation |
Institute | |
Department |
Funding Source | |
Organization | Kao Corporation |
Organization | |
Division | |
Category of Funding Organization | Profit organization |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Human Research Ethics Committee, Kao Corporation |
Address | 2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN |
Tel | +81-3-5630-9220 |
morisaki.naoko@kao.com |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions | 株式会社SOUKEN(東京都) |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Preinitiation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053259 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |